151 related articles for article (PubMed ID: 34284873)
1. Advances in the management of alveolar soft part sarcoma.
O'Sullivan Coyne G; Naqash AR; Sankaran H; Chen AP
Curr Probl Cancer; 2021 Aug; 45(4):100775. PubMed ID: 34284873
[TBL] [Abstract][Full Text] [Related]
2. Detection of ASPL/TFE3 fusion transcripts and the TFE3 antigen in formalin-fixed, paraffin-embedded tissue in a series of 18 cases of alveolar soft part sarcoma: useful diagnostic tools in cases with unusual histological features.
Williams A; Bartle G; Sumathi VP; Meis JM; Mangham DC; Grimer RJ; Kindblom LG
Virchows Arch; 2011 Mar; 458(3):291-300. PubMed ID: 21279521
[TBL] [Abstract][Full Text] [Related]
3. Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma.
Reis H; Hager T; Wohlschlaeger J; Bauer S; Katenkamp K; Katenkamp D; Baba HA
Hum Pathol; 2013 Oct; 44(10):2266-74. PubMed ID: 23871289
[TBL] [Abstract][Full Text] [Related]
4. [Detection of ASPL-TFE3 fusion gene by reverse transcriptase polymerase chain reaction in paraffin-embedded tumor tissues of alveolar soft part sarcoma].
Pang LJ; Li F; Chang B; Hu WH; Lu TC; Li XX; Li HA; Jiang JF
Zhonghua Bing Li Xue Za Zhi; 2004 Dec; 33(6):508-12. PubMed ID: 15634444
[TBL] [Abstract][Full Text] [Related]
5. Exploring the Histogenesis and Diagnostic Strategy Using Immunoassay and RT-PCR in Alveolar Soft Part Sarcoma.
Ju X; Sun K; Liu R; Li S; Abulajiang G; Zou H; Lan J; Ren Y; Jiang J; Liang W; Pang L; Li F
Pathol Oncol Res; 2018 Jul; 24(3):593-600. PubMed ID: 28766250
[TBL] [Abstract][Full Text] [Related]
6. Alveolar soft part sarcoma: a bimarker diagnostic strategy using TFE3 immunoassay and ASPL-TFE3 fusion transcripts in paraffin-embedded tumor tissues.
Pang LJ; Chang B; Zou H; Qi Y; Jiang JF; Li HA; Hu WH; Chen YZ; Liu CX; Zhang WJ; Li F
Diagn Mol Pathol; 2008 Dec; 17(4):245-52. PubMed ID: 18382356
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis, Prognosis, and Treatment of Alveolar Soft-Part Sarcoma: A Review.
Paoluzzi L; Maki RG
JAMA Oncol; 2019 Feb; 5(2):254-260. PubMed ID: 30347044
[TBL] [Abstract][Full Text] [Related]
8. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.
Ladanyi M; Lui MY; Antonescu CR; Krause-Boehm A; Meindl A; Argani P; Healey JH; Ueda T; Yoshikawa H; Meloni-Ehrig A; Sorensen PH; Mertens F; Mandahl N; van den Berghe H; Sciot R; Dal Cin P; Bridge J
Oncogene; 2001 Jan; 20(1):48-57. PubMed ID: 11244503
[TBL] [Abstract][Full Text] [Related]
9. Advances in treatment of alveolar soft part sarcoma: an updated review.
Fujiwara T; Kunisada T; Nakata E; Nishida K; Yanai H; Nakamura T; Tanaka K; Ozaki T
Jpn J Clin Oncol; 2023 Nov; 53(11):1009-1018. PubMed ID: 37626447
[TBL] [Abstract][Full Text] [Related]
10. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents.
Argani P; Antonescu CR; Illei PB; Lui MY; Timmons CF; Newbury R; Reuter VE; Garvin AJ; Perez-Atayde AR; Fletcher JA; Beckwith JB; Bridge JA; Ladanyi M
Am J Pathol; 2001 Jul; 159(1):179-92. PubMed ID: 11438465
[TBL] [Abstract][Full Text] [Related]
11. Molecular Landscape in Alveolar Soft Part Sarcoma: Implications for Molecular Targeted Therapy.
Soheilifar MH; Taheri RA; Zolfaghari Emameh R; Moshtaghian A; Kooshki H; Motie MR
Biomed Pharmacother; 2018 Jul; 103():889-896. PubMed ID: 29710505
[TBL] [Abstract][Full Text] [Related]
12. Genetics of rare mesenchymal tumors: implications for targeted treatment in DFSP, ASPS, CCS, GCTB and PEComa.
Rutkowski P; Przybył J; Świtaj T
Int J Biochem Cell Biol; 2014 Aug; 53():466-74. PubMed ID: 24704529
[TBL] [Abstract][Full Text] [Related]
13. A case of primary alveolar soft part sarcoma of the uterine cervix and a review of the literature.
Hasegawa K; Ichikawa R; Ishii R; Oe S; Kato R; Kobayashi Y; Kuroda M; Udagawa Y
Int J Clin Oncol; 2011 Dec; 16(6):751-8. PubMed ID: 21519815
[TBL] [Abstract][Full Text] [Related]
14. Expression of MET in alveolar soft part sarcoma.
Jun HJ; Lee J; Lim DH; Park JO; Ahn G; Seo SW; Sung KS; Lim DH; Yoo KH; Choi YL
Med Oncol; 2010 Jun; 27(2):459-65. PubMed ID: 19472090
[TBL] [Abstract][Full Text] [Related]
15. ASPL-TFE3 translocation in vulvovaginal alveolar soft part sarcoma.
Jabbour MN; Seoud M; Al-Ahmadie H; Abdul-Karim FW; Zaatari GS
Int J Gynecol Pathol; 2014 May; 33(3):263-7. PubMed ID: 24681737
[TBL] [Abstract][Full Text] [Related]
16. Alveolar Soft Part Sarcoma of the Female Genital Tract: A Morphologic, Immunohistochemical, and Molecular Cytogenetic Study of 10 Cases With Emphasis on its Distinction From Morphologic Mimics.
Schoolmeester JK; Carlson J; Keeney GL; Fritchie KJ; Oliva E; Young RH; Nucci MR
Am J Surg Pathol; 2017 May; 41(5):622-632. PubMed ID: 28009610
[TBL] [Abstract][Full Text] [Related]
17. Alveolar soft part sarcoma in children and young adults: A report of 69 cases.
Flores RJ; Harrison DJ; Federman NC; Furman WL; Huh WW; Broaddus EG; Okcu MF; Venkatramani R
Pediatr Blood Cancer; 2018 May; 65(5):e26953. PubMed ID: 29350467
[TBL] [Abstract][Full Text] [Related]
18. A case report and literature review on nephrogenic alveolar soft part sarcoma: clinicopathological manifestations and genetic features.
Wang X; Yu J; Fan X; Ma S; Xie X; Gao N; Huang S; Lu A
BMC Urol; 2023 Feb; 23(1):17. PubMed ID: 36782230
[TBL] [Abstract][Full Text] [Related]
19. Novel therapeutic options for alveolar soft part sarcoma: antiangiogenic therapy, immunotherapy and beyond.
Brahmi M; Vanacker H; Dufresne A
Curr Opin Oncol; 2020 Jul; 32(4):295-300. PubMed ID: 32541316
[TBL] [Abstract][Full Text] [Related]
20. Lingual alveolar soft part sarcoma with absent TFE3 rearrangement.
Alshahrani S; Khan A
Cancer Rep (Hoboken); 2021 Feb; 4(1):e1298. PubMed ID: 33026169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]